IP Library Granted Patent US 11,779,725
Granted Patent B2
US 11,779,725 · App. 16/988,185 · Granted Oct 10, 2023

Nitrogen dioxide storage device

Inventors: Barry N. Gellman (Melbourne, FL); Eddie Tajudeen (Orlando, FL); Lucas Gamero (Oviedo, FL); Joshua Hopkins (Casselberry, FL); Edward E. A. Bromberg (Orlando, FL); Ryan Denton (Central City, CO); Bryan J. Johnson (Orlando, FL); David Fine (Cocoa Beach, FL)
Assignee: VERO BIOTECH INC.
A61M16/12C01B21/24A61M16/107A61M2016/003A61M2016/0027A61M2202/0275A61M2205/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,779,725
App. No.
16/988,185
Granted
Oct 10, 2023
Kind
B2
Abstract

A nitric oxide delivery system can include a cassette which is a single use disposable component used to store liquid N 2 O 4 activate upon operator demand, convert N 2 O 4 to NO 2 via a heating element(s) controlled by a console to deliver NO 2 at a controlled flow rate, direct concentrated NO 2 to a contained pair of conversion cartridges and exhaust NO gas to the console for delivery to the patient.

Claims (45)

1. An apparatus, comprising:

an ampule;

a shuttle tube;

an inerting material configured to inert nitrogen dioxide;

a leak valve configured to couple the ampule to the inerting material when the shuttle tube is in a first position;

the ampule containing liquid dinitrogen tetroxide; and

the shuttle tube defining a reservoir, the ampule disposed in the reservoir, the shuttle tube configured to be moved between a first position in which the reservoir is fluidically coupled to the inerting material via the leak valve and a second position in which the reservoir is fluidically coupled to a patient delivery port.

2. The apparatus of claim 1 , wherein the reservoir is fluidically isolated from the patient delivery port when the shuttle tube is in the first orientation.

3. The apparatus of claim 1 , wherein the reservoir is fluidically isolated from the leak valve when the shuttle tube is in the second position.

4. The apparatus of claim 1 , wherein:

the reservoir is fluidically isolated from the patient delivery port when the shuttle tube is in the first orientation; and

the reservoir is fluidically isolated from the leak valve when the shuttle tube is in the second position.

5. The apparatus of claim 1 , wherein the shuttle is configured such that moving the shuttle from the first orientation to the second position causes the ampule to break.

6. The apparatus of claim 1 , wherein the shuttle is configured to rotate between the first position and the second position.

7. The apparatus of claim 1 , further comprising a heater configured to increase a temperature of the reservoir and pressure of nitrogen dioxide within the reservoir.

8. The apparatus of claim 1 , further comprising:

a heater configured to increase a temperature of the reservoir; and

a controller configured to control a flow rate of nitrogen dioxide through the patient delivery port by controlling the heater.

9. The apparatus of claim 1 , further comprising:

a first seal configured to fluidically isolate the reservoir from the patient delivery port when the shuttle is in the first position; and

a second seal configured to fluidically isolate the reservoir from the leak valve when the shuttle tube is in the second position.

10. The apparatus of claim 9 , further comprising:

a third seal redundant to the first seal, the third seal configured to fluidically isolate the reservoir from the patient delivery port when the shuttle is in the first position; and

a fourth seal redundant to the second seal, the fourth seal configured to fluidically isolate the reservoir from the leak valve when the shuttle tube is in the second position.

11. The apparatus of claim 1 , further comprising a spring biasing the shuttle towards the first position.

12. The apparatus of claim 1 , further comprising:

a spring biasing the shuttle towards the first position; and

an activation rod configured to move the shuttle from the first position to the second position, overcoming a force exerted by the spring.

13. The apparatus of claim 1 , wherein the shuttle is surrounded by inerting material.

14. The apparatus of claim 1 , wherein the ampule contains less than 0.53 ml of liquid dinitrogen tetroxide.

15. The apparatus of claim 1 , wherein the inerting material is configured such that it changes color from inerting nitrogen dioxide.

16. The apparatus of claim 1 , wherein:

the inerting material is configured such that it changes color from inerting nitrogen dioxide; and

the shuttle tube includes a transparent portion such that a color of the inerting material is visible.

17. The apparatus of claim 1 , wherein the shuttle tube, the ampule, the inerting material, and the leak valve are disposed within a housing of a cassette, the apparatus further comprising:

a console configured to be coupled to the cassette via the patient delivery port.

18. The apparatus of claim 1 , wherein the shuttle tube, the ampule, the inerting material, and the leak valve are disposed within a housing of a cassette, the apparatus further comprising:

a cartridge disposed within the housing of the cassette, the cartridge fluidically coupled to the shuttle tube via the patient delivery port, the cartridge configured to convert nitrogen dioxide to nitric oxide.

19. The apparatus of claim 1 , further comprising:

a housing of a cassette, the shuttle tube, the ampule, the inerting material, and the leak valve disposed within the housing of the cassette;

a seal within the housing of the cassette configured to fluidically couple the cassette to a valve of a console; and

a tamper-evident cover over the seal.

20. The apparatus of claim 1 , further comprising:

an activation rod configured to move the shuttle tube from the first position to the second position; and

a tamper-evident cover configured to be broken before the activation rod can be moved.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded May 31, 2023
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 063805/0495 →
CHANGE OF NAME Recorded Dec 23, 2022
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 062218/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2022
From: TAJUDEEN, EDDIE
To: VERO BIOTECH LLC
Reel/Frame 062198/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2022
From: GELLMAN, BARRY N.; GAMERO, LUCAS; HOPKINS, JOSHUA; BROMBERG, EDWARD; DENTON, RYAN; JOHNSON, BRYAN; FINE, DAVID
To: GENO LLC
Reel/Frame 062198/0351 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
Continuity (4)
Continuation 16283724 · Feb 22, 2019
Division 14918511 · Oct 20, 2015
Provisional Application 62066345 · Oct 20, 2014
Related Publication 20210121655A1 · Apr 29, 2021